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ABSTRACTS0627: ONCOLOGICAL OUTCOMES IN PATIENTS WHO UNDERWENT
GLANSECTOMY AND SKIN GRAFTING FOR TREATMENT OF PENILE
SQUAMOUS CELL CARCINOMA
Alastair McKay, John Scott. Canniesburn Plastic Surgery Unit, Glasgow Royal
Inﬁrmary, Glasgow, UK.
Introduction: Penile carcinoma is rare and the majority of disease is seen
as squamous cell carcinoma (SCC). 80% of disease is distally located and is
often amenable to penile preserving surgery. Glansectomy with split skin
grafting is a widely used procedure, however, only a small number of
centers have published data.
Methods: A retrospective review was undertaken of all patients who un-
derwent surgery for penile SCC under the care of a single surgical team.
Grading and staging of disease as well as complication and recurrence
rates were recorded.
Results: 12 out of a total of 14 patients underwent glansectomy and skin
grafting for penile SCC. Mean follow up was 18 months. The majority of
cases were T2G2. Disease speciﬁc survival was 92%. No local recurrence or
complications were seen.
Conclusions: Recurrence rates from this study were comparable with
other published data and the low complication rates seen here and else-
where also compare favorably to less invasive treatmentmodalities such as
radiotherapy. Compared with traditional, more radical surgery, glansec-
tomy with skin grafting offers good oncological control while preserving
penile length and function.
0629: TREATMENT OF INFANTILE HAEMANGIOMA WITH PROPRANO-
LOL IS BOTH SAFE AND EFFECTIVE
Harry Sargeant, Stephen Goldie, William Anderson. Plastic Surgery
Department, Royal Hospital for Sick Children, Edinburgh, UK.
Aim: Infantile haemangioma is the most common benign tumour affecting
young children. Although not present at birth, it can very rapidly prolif-
erate, causing problems with the child's development. During treatment of
Hypertrophic Obstructive Cardiomyopathy with Propanolol, an incidental
reduction in haemangioma size has been described. Our aim was to
demonstrate the effect of propranolol treatment alone on haemangioma
size whilst monitoring for any potential side effects.
Method: 74 children were treated for infantile haemangioma with pro-
pranolol, using a standard protocol. All of the children underwent a routine
series of cardiovascular investigations prior to commencing therapy, and
were monitored as inpatients for the initial 24 hours of treatment. Pre-
treatment photographs allowed an assessment of any change in the lesion.
In addition, the ﬁnal 13 patients underwent 3D photography allowing
more accurate evaluation of the growth or regression of the lesion.
Results: Subjective assessment using 2D photography demonstrated an
improvement in the majority of lesions. All of the patients measured with
3D photography showed a reduction in surface area and volume of their
haemangioma.
Conclusion: This study illustrates the safety and efﬁcacy of propranolol
treatment in a large series of infantile haemangiomas.
0649: AN AUDIT OF HUMAN BITES POST-EXPOSURE MANAGEMENT AT A
REGIONAL PLASTIC SURGERY DEPARTMENT
Tomos Longworth, George Lye, Sarah Hemington-Gorse. Wlesh Centre for
Burns & Plastic Surgery, Morriston Hospital, Swansea, UK.
Introduction: Reported cases indicate the transmission risk of Hepatitis
(Hep) B, C, and Human Immuno-deﬁciency Virus (HIV), via human bites.
The Health Protection Agency (HPA) produced management guidance on
the management for Human Bites. These stipulate blood-testing biter and
patient for Hep-B, Hep-C and HIV. Hep-B vaccination for those indicated
and screening at 6-weeks, 3-months and 6-months is recommended.
Methods: Case-note review of human bites managed by our department
over 12 months (1st June 2011 - 31st May 2012) established our practice.
Results: 32 patient-notes were reviewed. 84.5% (n¼27) were male (mean
age 32.12yrs). 84.5% (n¼27) sustained their injury ﬁghting, with 34% (n¼11)
intoxicated. Hep-B vaccination status was recorded in 9% (n¼3) of cases,
and given in 12.5% (n¼4) of occasions. No follow-up screening advice for
GPs was identiﬁed, and the infection status of all biters remains unknown.
Discussion: The usual circumstances when human bites inhibit the like-
lihood of reducing their incidence. By improving patient management we
limit the potential disastrous consequences. A poster highlightingrecommended management and investigation of human bites has been
displayed in all clinical areas of our department. We aim to reduce the
potential-risk of transmission and provide early diagnosis. We will re-
audit our practice soon.
0773: EVOLUTION OF OTOPLASTY TECHNIQUE: A REVIEW OF 126
CONSECUTIVE PATIENTS
Kai Yuen Wong, Ashvina Segaran, Natasha Aikman, Tariq Ahmad.
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Aim: Over 200 techniques have been described for prominent ear
correction. We describe our choice of procedure and evaluate the post-
operative outcomes of otoplasties performed by the senior author over a
10-year period.
Methods: Retrospective study of all otoplasties performed by the senior
author (2002-2012) at a single hospital. Preoperative assessment included
severity grading of ear prominence and cartilage stiffness. All patients
were sent questionnaires.
Results: A total of 126 patients (237 otoplasties) with a mean age of 10
years (range 3-23) were evaluated. Only absorbable sutures were used. A
posterior scoring technique was used in 191 otoplasties (80.5%). Scoring
was not used for the remaining procedures and this has been since 2010.
Complications occurred in 44 cases (18.6%) including asymmetry in 22
cases (9.3%) and recurrence in 13 cases (5.5%). Revisional surgery was
performed in 11 cases (4.6%). There were no haematomas. All patients
were satisﬁed with the improvement in appearance. Using multivariate
analysis with logistic regression, younger patients (p<0.05) and use of
posterior scoring (p<0.05) were both found to independently signiﬁcantly
increase the postoperative rate of asymmetry and recurrence.
Conclusion: Our evolved technique without the use of scoring is a safe
procedure with a high satisfaction rate.
0807: THE ONE-STOP CLINIC IN PLASTIC SURGERY e DEVELOPMENT OF
A NOVEL PROFORMA
Isabel Teo, Aidan Rose, Matthew Hough. Ninewells Hospital, Dundee, UK.
Introduction: The plastic surgery ‘one-stop' service offers a streamlined
approach to the diagnosis and management of day case skin cancer re-
ferrals. At this clinic, patients are assessed, consented and operated on in a
30-45 min time slot. Given the rapid turnover and variety of potential
outcomes from a one-stop appointment, accurate and meticulous docu-
mentation is imperative.
Aim: A retrospective audit of 50 consecutive one-stop patients was per-
formed to assess accuracy of documentation. We subsequently developed
a novel proforma aimed to improve documentation standards and per-
formed a further audit on 50 more cases to assess improvement.
Results: In the ﬁrst audit, only 5.1% documented any risks/complications,
8% date/time and 25% documented the depth of excision. Using the new
proforma, we found a statistically signiﬁcant improvement in documen-
tation of risks/complications [5.1% (2/50) to 100% (50/50)], date and time
[8%(4/50) to 76%(38/50)], consultant [30% (15/50)to 94% (47/50)] and grade
of surgeon [28% (14/50) to 100%].
Conclusion: Standards of documentation are difﬁcult of maintain in a busy
one-stop clinic. This pre-printed consent form and standardised operative
record has been shown to improve documentation. We will continue to
audit our performance, and ensure that meticulous standards are
maintained.
0808: SENTINEL LYMPH NODE BIOPSY FOR CUTANEOUS MALIGNANT
MELANOMA-OUTCOMES OF 199 CONSECUTIVE CASES
Flossie Carpenter, Isabel Teo, Aidan Rose, Matthew Hough. Ninewells
Hospital, Dundee, UK.
Aims: To audit outcomes following sentinel lymph node biopsy (SLNB) for
malignant melanoma, using the MSLT (Multicentre Selective Lymphade-
nectomy Trial) data as benchmarking standards.
Methods: We retrospectively analysed the case notes of all patients who
had undergone SLNB at a single centre from 2003 to 2011.
Results: 199 patients were identiﬁed. The identiﬁcation rate is 95.5% (190/
199) compared to the standard of 99.3% (764/769). The incidence of pos-
itive SLN is 18.1% (36/199), compared to the standard 16% (122/764). The
rate of false negative results was 9.8% (4/41) compared to the standard 3.4%
(26/764). The melanoma-speciﬁc mortality is 14.2% (19/124) when the SLN
